Example: Heart Attack

Search clinical trials for: Modulation of FiO2

Total 10000 results

NCT00546936

Unknown

Ranibizumab Versus PDT for Presumed Ocular Histoplasmosis

Presumed Ocular Histoplasmosis (POHS)
NCT00378872

Completed

Tranexamic Acid vs. Quixil - Reducing Blood Loss in Joint Replacement

Hemorrhage | Arthroplasty, Replacement, Knee | Arthroplasty, Replacement, Hip
NCT00187408

Completed

The D-KAF (Dalteparin in Knee-to-Ankle Fracture) Trial

Deep Vein Thrombosis | Pulmonary Embolism
NCT06881537

Recruiting

CapeOX Combined With Bevacizumab Plus Anti-PD1 Antibody as Neoadjuvant Therapy for Locally Recurrent Colorectal Cancer

Locally Recurrent Colorectal Cancer
NCT05886465

Recruiting

HAIC Plus A+T for Patients With High-risk HCC: a Single-arm Phase 2 Trial

Hepatocellular Carcinoma
NCT04356729

Active, not recruiting

A Phase II Trial of PD-L1 Therapy Combined With Anti-VEGF Therapy in Unresectable or Metastatic Melanoma

Stage IV Melanoma | Clinical Stage III Cutaneous Melanoma AJCC v8 | Unresectable Stage III Cutaneous Melanoma | Unresectable Stage IV Cutaneous Melanoma
NCT06713785

Withdrawn

Personalised Electronic Record Supported Optimisation of Amlodipine for Patients With Hypertension (PERSONAL HTN)

Hypertension
NCT03363867

Active, not recruiting

BEACON - ABC in Recurrent Platinum Resistant HGSOC (BEACON)

Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Carcinoma
NCT04368546

Completed

Sunitinib Treatment on Tissue Sodium Accumulation (TSS2)

Hypertension | Renal Cell Cancer Metastatic | Sodium Imbalance
NCT01742273

Terminated

Vitamin K1 to Slow Progression of Vascular Calcification in HD Patients (VitaVasK)

Cardiovascular Diseases
NCT04111289

Unknown

Effect of Upstream High Bolus Dose of Tirofiban in Primary PCI for the Patients With STEMI on Short Term Outcome (TISP)

High Bolus Dose of Tirofiban
NCT02890875

Terminated

Efficacy and Safety of Ethanol Lock Therapy for the Prevention of Central Line-associated Bloodstream Infections

Catheter-Related Infections
NCT02919371

Unknown

Combined Alternating Sunitinib and Bevacizumab (Avastin®) in Advanced Renal Cell Carcinoma (CASA)

Renal Cell Carcinoma
NCT02330783

Unknown

Efficacy and Safety of Bevacizumab Plus Sorafenib for the Third-line Treatment in Metastatic Renal Cancer Patients

Metastatic Renal Cell Carcinoma
NCT01738646

Completed

Ph II SAHA and Bevacizumab for Recurrent Malignant Glioma Patients

Malignant Glioma | Recurrent Glioblastoma Multiforme | Adult Brain Tumor
NCT02393612

Completed

Clinical Trial to Evaluate Efficacy and Safety of DP-R202 and Anplag in Patients With Artery Occlusive Disease (DAVICI)

Peripheral Arterial Disease
NCT00403156

Withdrawn

Imatinib Mesylate Combined With Intravitreal Ranibizumab in the Treatment of Choroidal Neovascularization Secondary to Age-Related Macular Degeneration

Choroidal Neovascularization
NCT00387335

Completed

Sunitinib in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer

Recurrent Metastatic Squamous Neck Cancer With Occult Primary | Recurrent Squamous Cell Carcinoma of the Hypopharynx | Recurrent Squamous Cell Carcinoma of the Larynx | Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity | Recurrent Squamous Cell Carcinoma of the Oropharynx | Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity | Recurrent Squamous Cell Carcinoma of the Nasopharynx | Stage IV Squamous Cell Carcinoma of the Hypopharynx | Stage IV Squamous Cell Carcinoma of the Larynx | Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity
NCT00923234

Terminated

Combination of 5-azacitidine and Lenalidomide in Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML) Myelodysplastic Syndromes (AZALE)

Myelodysplastic Syndromes | Acute Myelogenous Leukemia
NCT00265317

Completed

A Study In Patients With Non-Small Cell Lung Cancer Testing If Erlotinib Plus SU011248 (Sunitinib) Is Better Than Erlotinib Alone (SUN1058)

Carcinoma, Non-Small-Cell Lung
NCT00253344

Completed

Lenalidomide and Docetaxel in Treating Patients With Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific
NCT00352742

Terminated

A Study of ATN-224 and Bortezomib in Patients With Multiple Myeloma

Multiple Myeloma
NCT01822405

Unknown

Treatment of Radiation-induced Fibrosis in the Upper Aerodigestive Tract Cancer by a Combination of Pentoxifylline-tocopherol and Hyperbaric Oxygen (ORT-OXI-2009)

Fibrosis
NCT07179809

Not yet recruiting

Group-based Comprehensive Lifestyle Program for Women With Metastatic Breast Cancer

Metastatic Breast Cancer
NCT07553897

Completed

Tele-exercise Training Program for Long COVID

Long COVID
NCT06440278

Active, not recruiting

Healthy Heart Habits-2 (HHH-2)

Acute Coronary Syndrome
NCT07520123

Not yet recruiting

Union-FAST: An Intelligent-Agent Intervention to Increase Antiviral Treatment Uptake in Diagnosed-but-Untreated Hepatitis B Patients (Union-FAST)

Chronic Hepatitis B
NCT04109235

Recruiting

Family Health Team High-Intensity Interval Training (FHT HIIT)

Type 2 Diabetes
NCT06682468

Active, not recruiting

Achieving Equity in Patient Outcome Reporting for Timely Assessments of Life With HIV and Substance Use (ePORTAL-HIV-S)

HIV | Substance Use Disorders
NCT06404047

Completed

RECOVER-ENERGIZE Platform Protocol

Long COVID | Long Covid19 | Long Covid-19
NCT03366922

Completed

Evaluation of Artemisia Annua and Moringa

HIV Infections
NCT05644795

Completed

Wheat-free Diet in the Treatment of Sjogren's Syndrome

Sjogren's Syndrome | Non-celiac Gluten Sensitivity
NCT03979625

Completed

Prognosis Related to Induced Thrombopenia With Heparin Under Venoarterial ECMO in Reanimation (TIH ECMO)

Heparin-induced Thrombocytopenia
NCT03558750

Terminated

Rituximab, Lenalidomide, and Nivolumab in Treating Participants With Relapsed or Refractory Non-Germinal Center Type Diffuse Large B Cell Lymphoma or Primary Central Nervous System Lymphoma

Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Refractory Central Nervous System Lymphoma | Recurrent Central Nervous System Lymphoma
NCT06917092

Recruiting

QL1706-Based Therapy Post-PD-1/L1 Failure in Advanced Endometrial Cancer (QLPPEC/GOG-003)

Endometrial Cancer | Endometrial Adenocarcinoma
NCT06860490

Recruiting

HAIC Combined With Sintilimab Plus Bevacizumab Biosimilar for Advanced Hepatocellular Carcinoma (TASK-03)

Hepatocellular Carcinoma (HCC)
NCT06519422

Not yet recruiting

Tranexamic Acid for Anaemia Trial (WOMAN-3)

Anemia
NCT06515535

Not yet recruiting

Efficacy of Topical Tranexamic Acid in Reducing Blood Loss During CS in Patients With Placenta Previa

Placenta Previa
NCT06420973

Recruiting

RC48 Treatment for Platinum Sensitive Recurrent Ovarian Cancer With HER2 Expression

Fallopian Tube Carcinoma | Ovarian Carcinoma | Primary Peritoneal Carcinoma
NCT06270407

Recruiting

The Effect of Local Application of Tranexamic Acid Versus Placebo on Postoperative Complications in Plastic Surgery (TRANOP)

Surgical Complication
NCT05970666

Recruiting

Single Arm, Prospective, Multicenter Clinical Study of TACE With Adebrelimab and Bevacizumab for Unresectable Hepatocellular Carcinoma

Hepatocellular Carcinoma | Bevacizumab | TACE | Adebrelimab | Transformation
NCT05883176

Not yet recruiting

TACE Combined With Bevacizumab in HCC (BCLC-B) Beyond Up-To-Seven Criteria (B-TACE)

Hepatocellular Carcinoma by BCLC Stage
NCT05811793

Not yet recruiting

Efficacy and Safety of SCAI of Bevacizumab Combined With IC of Tislelizumab in the Treatment of Recurrent Glioblastoma.

Glioblastoma
NCT05771883

Not yet recruiting

A Clinical Study of Injectable IMM0306 in Combination With Lenalidomide

B-cell Non-Hodgkin's Lymphoma
NCT05540275

Not yet recruiting

Tislelizumab (One Anti-PD-1 Antibody) Plus Low-dose Bevacizumab for Bevacizumab Refractory Recurrent Glioblastoma

Recurrent Glioblastoma
NCT05512351

Recruiting

Sintilimab (One Anti-PD-1 Antibody) Plus Low-dose Bevacizumab for ctDNAlevel- Relapse and Clinical-relapse Oligodendroglioma

Oligodendroglioma
NCT05314101

Recruiting

TAS-102 Combined With Bevacizumab and Tislelizumab Third-line or Above in the Treatment of Liver Metastasis in Colorectal Cancer

Colorectal Cancer | Immunotherapy
NCT05248334

Recruiting

A Prospective Study of Ranibizumab in the Treatment of Postoperative Recurrent Vitreous Haemorrhage of Diabetic Retinopathy

Diabetic Retinopathy | Pars Plana Vitrectomy | Ranibizumab | Postoperative Recurrent Vitreous Hemorrhage
NCT05185505

Not yet recruiting

Atezolizumab and Bevacizumab Pre-Liver Transplantation for Patients With Hepatocellular Carcinoma Beyond Milan Criteria

Hepatocellular Carcinoma | Hepatocellular Cancer
NCT04910464

Recruiting

Early Tranexamic Acid and Modulating the Inflammatory Response in Sepsis

Sepsis

Search clinical trials for: Modulation of FiO2

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations